Endometrial Evaluation in Elagolix-Treated Women With Uterine Fibroids and Heavy Menstrual Bleeding [25G]

INTRODUCTION:Elagolix, an oral gonadotropin-releasing hormone antagonist, with and without add-back therapy, was evaluated in premenopausal women with heavy menstrual bleeding (HMB; >80mL/month) associated with uterine fibroids (UF).METHODS:This double-blind phase-2b study (NCT01817530) enrolled wom